Double maintains 1 strategies that include SANA - Sana Biotechnology, Inc.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -22.18% | $298.87M | 1.43% |
IBMP | -21.54% | $541.08M | 0.18% |
VIXY | -18.09% | $153.01M | 0.85% |
TAIL | -16.28% | $107.77M | 0.59% |
KCCA | -12.38% | $93.93M | 0.87% |
FXY | -11.75% | $857.17M | 0.4% |
BSMW | -11.52% | $102.07M | 0.18% |
XHLF | -10.58% | $1.64B | 0.03% |
WIP | -10.38% | $352.89M | 0.5% |
UDN | -8.93% | $145.23M | 0.78% |
KRBN | -8.67% | $161.71M | 0.85% |
SHYM | -8.51% | $324.05M | 0.35% |
ULST | -8.42% | $663.99M | 0.2% |
MLN | -8.39% | $523.40M | 0.24% |
DFNM | -8.20% | $1.56B | 0.17% |
BWX | -8.19% | $1.40B | 0.35% |
FXB | -8.18% | $84.63M | 0.4% |
SPTS | -7.80% | $5.78B | 0.03% |
XONE | -7.52% | $634.70M | 0.03% |
CTA | -7.47% | $1.09B | 0.76% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FXU | -<0.01% | $1.64B | 0.64% |
EMBD | -0.02% | $223.68M | 0.39% |
PWZ | -0.04% | $702.78M | 0.28% |
LGOV | -0.14% | $689.06M | 0.67% |
EDV | -0.16% | $3.33B | 0.05% |
NUAG | 0.16% | $57.79M | 0.19% |
TLT | -0.18% | $48.66B | 0.15% |
IDU | -0.18% | $1.51B | 0.39% |
BIV | -0.19% | $22.59B | 0.03% |
GVI | -0.24% | $3.36B | 0.2% |
UCON | -0.25% | $2.97B | 0.86% |
FLCB | -0.28% | $2.55B | 0.15% |
FTSM | 0.30% | $6.46B | 0.45% |
MSOS | 0.31% | $307.59M | 0.77% |
ZROZ | -0.31% | $1.49B | 0.15% |
AGG | -0.32% | $125.44B | 0.03% |
VCSH | 0.32% | $34.34B | 0.03% |
HYD | -0.36% | $3.28B | 0.32% |
FLDR | -0.36% | $933.34M | 0.15% |
SPSB | -0.36% | $8.19B | 0.04% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GNOM | 33.11% | $44.34M | 0.5% |
ARKG | 29.57% | $980.60M | 0.75% |
PBE | 29.47% | $229.19M | 0.58% |
XBI | 27.30% | $4.89B | 0.35% |
XHB | 25.76% | $1.21B | 0.35% |
FBT | 25.53% | $1.05B | 0.54% |
SMLF | 23.96% | $1.76B | 0.15% |
XSMO | 23.76% | $1.62B | 0.39% |
ITB | 23.70% | $2.08B | 0.39% |
PTH | 23.58% | $104.10M | 0.6% |
IJT | 23.47% | $6.07B | 0.18% |
ONLN | 23.41% | $80.99M | 0.58% |
SLYG | 23.25% | $3.36B | 0.15% |
IBB | 23.25% | $5.23B | 0.45% |
XMHQ | 23.22% | $5.03B | 0.25% |
IJK | 22.88% | $8.76B | 0.17% |
MDYG | 22.86% | $2.24B | 0.15% |
PRFZ | 22.84% | $2.36B | 0.34% |
JMEE | 22.83% | $1.82B | 0.24% |
GRPM | 22.62% | $451.21M | 0.35% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CLRB | -0.02% | $19.67M | -87.18% | 0.00% |
CNK | -0.02% | $3.70B | +79.80% | 0.50% |
ETR | -0.03% | $35.39B | +53.04% | 4.26% |
EXK | -0.04% | $1.44B | +38.94% | 0.00% |
BP | -0.05% | $80.10B | -13.36% | 6.18% |
MSDL | 0.05% | $1.69B | -14.85% | 10.31% |
HRZN | -0.05% | - | - | 17.44% |
MBLY | -0.05% | $13.28B | -44.24% | 0.00% |
FMX | -0.08% | $21.89B | -0.59% | 4.22% |
PZZA | -0.08% | $1.70B | +7.45% | 3.59% |
WDS | 0.10% | $29.61B | -15.15% | 7.87% |
SUNS | 0.11% | $150.19M | -0.97% | 8.42% |
KNOP | 0.11% | $226.19M | -7.37% | 1.57% |
PRGS | -0.12% | $2.71B | +24.76% | 0.28% |
APRE | 0.14% | $10.12M | -57.64% | 0.00% |
X | 0.15% | $12.11B | +43.61% | 0.37% |
NERV | -0.16% | $12.10M | -46.28% | 0.00% |
ELS | 0.16% | $11.97B | +2.19% | 3.10% |
CNP | 0.16% | $23.52B | +16.26% | 2.36% |
BKH | -0.17% | $4.17B | +8.68% | 4.63% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
VIR | 73.99% | $725.75M | -49.90% | 0.00% |
ANGO | 57.74% | $442.62M | +77.52% | 0.00% |
CPRX | 48.68% | $3.10B | +64.47% | 0.00% |
MATW | 42.11% | $702.97M | -16.81% | 4.40% |
COLL | 41.86% | $954.30M | -6.87% | 0.00% |
EBAY | 40.24% | $35.90B | +46.42% | 1.45% |
AIR | 31.66% | $2.46B | +1.62% | 0.00% |
CALX | 27.66% | $3.10B | +31.94% | 0.00% |
MSM | 27.09% | $4.58B | -3.56% | 4.14% |
ROKU | 26.91% | $11.80B | +42.80% | 0.00% |
PACB | 26.83% | $348.10M | -41.41% | 0.00% |
AYI | 26.53% | $8.48B | +6.78% | 0.24% |
MTH | 26.30% | $4.72B | -22.77% | 4.08% |
TOL | 26.26% | $10.74B | -8.89% | 0.86% |
LFVN | 26.25% | $159.24M | +69.34% | 1.30% |
OXM | 26.15% | $744.19M | -50.48% | 6.14% |
CXT | 26.04% | $3.19B | -8.37% | 1.19% |
ADTN | 25.92% | $627.02M | +50.19% | 0.00% |
OPFI | 25.86% | $1.21B | +338.51% | 0.00% |
CRSP | 25.64% | $3.59B | -35.96% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RCEL | -24.91% | $150.55M | -31.53% | 0.00% |
EIX | -23.74% | $19.09B | -32.55% | 6.47% |
IONQ | -17.82% | $10.39B | +399.37% | 0.00% |
JNJ | -12.87% | $373.57B | +6.77% | 3.23% |
SYPR | -12.86% | $44.35M | +2.66% | 0.00% |
LPTH | -12.38% | $123.12M | +133.33% | 0.00% |
KR | -11.51% | $43.03B | +28.80% | 1.97% |
VSTA | -11.46% | $331.23M | +31.32% | 0.00% |
FMTO | -11.36% | $5.10K | -99.92% | 0.00% |
CWT | -10.49% | $2.78B | -2.13% | 2.50% |
RELL | -9.19% | $133.25M | -18.51% | 2.58% |
CWEN | -9.04% | $3.65B | +14.74% | 5.45% |
CWEN.A | -8.78% | $3.44B | +18.30% | 5.80% |
KLG | -8.75% | $1.34B | -13.61% | 4.13% |
DG | -8.65% | $24.53B | -10.79% | 2.13% |
KRP | -8.55% | $1.30B | -17.70% | 12.11% |
CBOE | -8.35% | $23.34B | +31.58% | 1.12% |
ATOM | -8.22% | $191.90M | +60.26% | 0.00% |
MBI | -8.16% | $216.60M | -19.32% | 0.00% |
EDN | -8.08% | $690.95M | +88.71% | 0.00% |
Current Value
$2.661 Year Return
Current Value
$2.661 Year Return
Yahoo
The market has climbed 1.3% over the last week and is up 13% over the past year, with earnings forecasted to grow by 14% annually. For those looking to invest in smaller or newer companies, penny stocks—despite their vintage name—can still offer surprising value. We've selected three examples of penny stocks that combine balance sheet strength with potential for outsized gains, giving investors the chance to discover hidden value in quality companies.
Finnhub
Presenter SpeechSalveen Richter Great. Good morning, everyone. Thank you so much for joining us. Really pleased to have with us this morning Dr. Steve Harr, who's the President and CEO of Sana...
Yahoo
Presentation to highlight updated six-month clinical results of a hypoimmune-modified primary pancreatic islet cell therapy for patients with type 1 diabetesSEATTLE, June 09, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced an upcoming podium presentation highlighting ongoing clinical data from the investigator-sponsored, first-in-human study transplanting UP421, an allogeneic prima
Finnhub
Sana Biotechnology Inc: * SANA BIOTECHNOLOGY ANNOUNCES INVITED ORAL PRESENTATION ATTHE85TH ANNUAL AMERICAN DIABETES ASSOCIATION SCIENTIFIC SESSIONSSource text:Further company...
Finnhub
Presenter SpeechCha Cha Yang Hi, everyone. Thank you so much for joining us for the Sana presentation. My name is Cha Cha. I'm a biotech equity research senior associate based out of Boston. Really...
Yahoo
SEATTLE, May 28, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences in June. The presentations will feature a business overview and update. Sana will present at the Jefferies Global Healthcare Conference at 2:35 p.m. ET on Wednesday, June 4, 2025.Sana will present at the Goldman Sachs 46th Annual Global Healthcare Conf